Achilles Therapeutics plc
ACHL
$1.48
$0.010.68%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -19.60M | -16.38M | -12.27M | -18.63M | -16.68M |
| Total Depreciation and Amortization | 1.20M | 1.18M | 1.18M | 1.15M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.86M | 1.36M | 1.40M | 1.29M | 1.67M |
| Change in Net Operating Assets | 2.27M | -3.47M | -7.81M | 2.01M | 14.81M |
| Cash from Operations | -14.26M | -17.31M | -17.51M | -14.19M | 1.00M |
| Capital Expenditure | -28.00K | -36.00K | -695.00K | -46.00K | -63.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.00K | -36.00K | -695.00K | -46.00K | -63.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.00K | 0.00 | 5.00K | 0.00 | 8.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.00K | 0.00 | 5.00K | 0.00 | 8.00K |
| Foreign Exchange rate Adjustments | 5.19M | 153.00K | -1.02M | 5.64M | -4.52M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.09M | -17.19M | -19.22M | -8.60M | -3.57M |
